Temporal incremental healthcare costs associated with complications in Hong Kong Chinese patients with type 2 diabetes: A prospective study in Joint Asia diabetes evaluation (JADE) Register (2007-2019) [0.03%]
香港糖尿病患者并发症相关的医疗费用及成本增量：亚洲糖尿病评估注册前瞻性研究(2007-2019年)
Juliana N M Lui,Eric S H Lau,Abby Q Y Li et al.
Juliana N M Lui et al.
Objective: We examined incremental healthcare costs (inpatient and outpatient) related to complications in Chinese patients with type 2 diabetes (T2D) during the year of occurrence and post-event years, utilizing the Join...
Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study [0.03%]
中国2型糖尿病患者使用达格列净联合二甲双胍治疗的现实世界安全性：DONATE研究的事后分析
Lixin Guo,Jing Wang,Li Li et al.
Lixin Guo et al.
Aim: DONATE (NCT03156985) is a large-scale real-world study investigating the safety of dapagliflozin in Chinese type 2 diabetes mellitus (T2DM) patients. This post-hoc analysis aims to further evaluate the real-world saf...
Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease [0.03%]
2型糖尿病和PNPLA3小等位基因一致地识别出与代谢功能异常相关脂肪肝的高风险患者
Zobair M Younossi,J Michael Estep,Sean Felix et al.
Zobair M Younossi et al.
Background: Association of genetic factors with non-invasive tests (NITs) for MASLD has not been well established. Methods: Clinical an...
Efficacy of flash glucose monitoring on HbA1c in type 2 diabetes: An individual patient data meta-analysis of real-world evidence [0.03%]
动态葡萄糖监测对2型糖尿病患者HbA1c影响的个体患者数据meta分析研究
Randeep S Heer,Joshua Lovegrove,Zoë Welsh
Randeep S Heer
Aims: There is a growing body of evidence demonstrating the benefit of flash glucose monitoring in type 2 diabetes mellitus (T2DM). This individual patient data meta-analysis aimed to investigate the impact of commencing ...
High one-hour plasma glucose is an intermediate risk state and an early predictor of type 2 diabetes in a longitudinal Korean cohort [0.03%]
基于韩国纵向队列研究的高一小时血糖是2型糖尿病的中间风险状态和早期预测因素
Myungsoo Im,Jinmi Kim,Soree Ryang et al.
Myungsoo Im et al.
Aims: Because one-hour post-load plasma glucose (1h-PG) ≥ 155 mg/dL (8.6 mmol/L) has been proposed as an early marker for future diabetes but lacks sufficient longitudinal confirmation of its risk, we aimed to evaluate t...
Differences in target organ damage in individuals with intermediate hyperglycemia and type 2 diabetes identified by 1-hour plasma glucose during an oral glucose tolerance test [0.03%]
口服葡萄糖耐量试验1小时血浆血糖诊断的糖耐量异常与2型糖尿病患者靶器官损害的差异分析
Chiara Maria Assunta Cefalo,Alessia Riccio,Teresa Vanessa Fiorentino et al.
Chiara Maria Assunta Cefalo et al.
Aims: The International Diabetes Federation (IDF) has recently recommended determination of 1-hour glucose during an oral glucose tolerance test (OGTT) to diagnose intermediate hyperglycemia (IH) and type 2 diabetes (T2D)...
Corrigendum to "Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study" [Diabetes Res. Clin. Pract. 186 (2022) 109816] [0.03%]
关于“钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者泌尿生殖系统首次和复发感染的风险因素：一项回顾性队列研究”的勘误注释[糖尿病研究与临床实践杂志，卷186（2022），文章号109816]
Yi-Hsuan Lin,Chia-Hung Lin,Yu-Yao Huang et al.
Yi-Hsuan Lin et al.
Global, regional, and national burden of type 2 diabetes mellitus attributable to particulate matter pollution from 1990 to 2021: An analysis of the global burden of disease study 2021 [0.03%]
1990年至2021年全球、区域和国家范围内归因于颗粒物污染的2型糖尿病负担：2021年全球疾病负担研究分析
Diya Xie,Zhang Shen,Lihang Yang et al.
Diya Xie et al.
Aims: The study uses GBD 2021 data to measure the type 2 diabetes mellitus (T2DM) burden linked to particulate matter pollution (PM2.5) exposure, highlighting environmental factors as rising contributors to the disease. ...
Target gene variations of PPAR isoforms may contribute to MODY heterogeneity: A preliminary comparative study with type 2 diabetes [0.03%]
PPAR同工酶的目标基因变异可能会导致MODY的异质性：与2型糖尿病初步比较研究
Hulya Yilmaz-Aydogan,Deniz Kanca-Demirci,Nurdan Gul et al.
Hulya Yilmaz-Aydogan et al.
Aims: The objective of this study was to evaluate the associations of several genetic variants of peroxisome proliferator-activated receptors (PPARs) on clinical and laboratory parameters in patients with maturity-onset d...
Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years [0.03%]
口服塞马鲁肽的现实世界有效性：重点关注75岁以上2型糖尿病患者
Walter Baronti,Cristina Lencioni,Margherita Occhipinti et al.
Walter Baronti et al.
Aim: Data on the efficacy of oral semaglutide (OS) in elderly patients with type 2 diabetes are still lacking. This study evaluates the effectiveness of OS in a real world setting with a large ≥75 year old population. ...